Clinical Trial Update: Clarithromycin in Multiple Myeloma Induction Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating clarithromycin as part of induction therapy for multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Henrik Gregersen | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED